BioVaxys Technology (BioVaxys Technology) Days Sales Outstanding : 0.00 (As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Days Sales Outstanding?

BioVaxys Technology's average Accounts Receivable for the three months ended in Jul. 2023 was $0.00 Mil. BioVaxys Technology's Revenue for the three months ended in Jul. 2023 was $0.00 Mil.

The historical rank and industry rank for BioVaxys Technology's Days Sales Outstanding or its related term are showing as below:

BVAXF's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.34
* Ranked among companies with meaningful Days Sales Outstanding only.

BioVaxys Technology's Days Sales Outstanding stayed the same from Jul. 2022 (0.00) to Jul. 2023 (0.00).

BioVaxys Technology Days Sales Outstanding Historical Data

The historical data trend for BioVaxys Technology's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Days Sales Outstanding Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Days Sales Outstanding

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BioVaxys Technology's Days Sales Outstanding

For the Biotechnology subindustry, BioVaxys Technology's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioVaxys Technology's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's Days Sales Outstanding falls into.

BioVaxys Technology Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BioVaxys Technology's Days Sales Outstanding for the fiscal year that ended in Oct. 2022 is calculated as

	Days Sales Outstanding (A: Oct. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2021 )	+	Accounts Receivable (A: Oct. 2022 ))	/	count )	/	Revenue (A: Oct. 2022 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

BioVaxys Technology's Days Sales Outstanding for the quarter that ended in Jul. 2023 is calculated as:

	Days Sales Outstanding (Q: Jul. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Apr. 2023 )	+	Accounts Receivable (A: Jul. 2023 ))	/	count )	/	Revenue (A: Jul. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

BioVaxys Technology (OTCPK:BVAXF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

BioVaxys Technology Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.